AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 204248
Drug: 0.02% solution
RxNorm normalized name: Atrovent 0.02% Solution for Inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.02% solution of prodigiosan administered intranasally (0.2 ml once every 4 days for 4 months)
Trial: 21422866
Drug: Vaginal pH-balanced
RxNorm normalized name: Fem pH Vaginal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal pH-balanced gel (administered three times per week for 12 weeks)
Trial: 21422866
Drug: Placebo (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (administered three times per week for 12 weeks)
Trial: 19363969
Drug: Three 15-minute
RxNorm normalized name: THREE-LOBE SAGE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three 15-minute in-office bleaching treatments with 36% hydrogen peroxide followed by at-home overnight bleaching with 15% carbamide peroxide for seven days.
Trial: 19363969
Drug: 40-minute in-office
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40-minute in-office bleaching treatment followed by at-home overnight bleaching for seven days.
Trial: 19363969
Drug: In-office treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-office treatment without at-home bleaching.
Trial: 15226561
Drug: Cefpodoxime 5
RxNorm normalized name: cefpodoxime 50 MG in 5 mL Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefpodoxime 5 mg/kg b.i.d. for 10-14 days
Trial: 15226561
Drug: Cefixime 4
RxNorm normalized name: cefixime 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 4 mg/kg b.i.d. for 10-14 days
Trial: 2462943
Drug: MOPP chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MOPP chemotherapy and RT
Trial: 1276818
Drug: Medium-dose corticosteroids
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-dose corticosteroids
Trial: 21948693
Drug: Physical exercise
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical exercise group (PEG) - 60 minutes of supervised exercise twice a week for 8 weeks
Trial: 15756184
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of morphine, bupivacaine, and epinephrine
Trial: 15756184
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of bupivacaine and epinephrine
Trial: 15756184
Drug: Preoperative analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative analgesic injections
Trial: 15756184
Drug: Postoperative analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative analgesic injections
Trial: 15756184
Drug: Preoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative treatment medication
Trial: 10214482
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg intramuscular ketorolac upon surgical closure and every 6 hours for 36 hours and narcotic analgesics as needed (PRN)
Trial: 10214482
Drug: Only narcotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Only narcotic analgesics as needed
Trial: 7793999
Drug: UFT (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT (400 or 600 mg/body per day)
Trial: 11605931
Drug: rapacuronium (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rapacuronium (1.5 mg/kg)
Trial: 11605931
Drug: cis-atracurium (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cis-atracurium (0.2 mg/kg)
Trial: 27236292
Drug: Active low-level
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active low-level laser therapy (LLLT)
Trial: 30244669
Drug: Placebo low-level
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo low-level laser therapy (LLLT)
Trial: 19837071
Drug: Famotidine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine (40 mg, morning and evening)
Trial: 19837071
Drug: Pantoprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole (20 mg in the morning and placebo in the evening)
Trial: 9527781
Drug: Indinavir sulfate
RxNorm normalized name: Indinavir Sulfate
DrugBank: Indinavir (DB00224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indinavir sulfate 400 mg
Trial: 9527781
Drug: Indinavir sulfate
RxNorm normalized name: Indinavir Sulfate
DrugBank: Indinavir (DB00224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indinavir sulfate 800 mg
Trial: 8544974
Drug: Cigarette smoking
RxNorm normalized name: Cigarette smoking tobacco
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarette smoking with nicotine levels of < 0.1 mg
Trial: 8544974
Drug: Cigarette smoking
RxNorm normalized name: Cigarette smoking tobacco
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarette smoking with nicotine levels of 0.6 mg
Trial: 8544974
Drug: Cigarette smoking
RxNorm normalized name: Cigarette smoking tobacco
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarette smoking with nicotine levels of 1.0 mg
Trial: 8544974
Drug: Cigarette smoking
RxNorm normalized name: Cigarette smoking tobacco
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarette smoking with nicotine levels of 2.1 mg
Trial: 2404478
Drug: Dietary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary treatment leading to normalization of hemoglobin A1 value to 7.0% +/- 0.3%
Trial: 2404478
Drug: Dietary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary treatment with persistent hyperglycemia (hemoglobin A1 value, 10.7% +/- 0.7%)
Trial: 30646965
Drug: Gabapentin (accumulating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (accumulating dose of 45 to 63 mg/kg/day, dependent on age) as add-on to morphine
Trial: 30646965
Drug: Placebo as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo as add-on to morphine
Trial: 6750532
Drug: Acyclovir therapy
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir therapy (5 to 10 mg/kg/8 hours, 60 minutes intravenous infusions, three times a day for 6 or 11 days)
Trial: 3010782
Drug: Acyclovir therapy
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir therapy
Trial: 31679946
Drug: Elexacaftor 200
RxNorm normalized name: Elexacaftor
DrugBank: Elexacaftor (DB15444)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Elexacaftor 200 mg orally once daily plus tezacaftor 100 mg orally once daily plus ivacaftor 150 mg orally every 12 h
Trial: 17032159
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy plus treatment as usual
Trial: 10946861
Drug: 17beta-estradiol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17beta-estradiol (1 mg twice daily orally)
Trial: 12030918
Drug: GHRP-2 infusion
RxNorm normalized name: Interleukin-2/diptheria toxin fusion protein
DrugBank: Denileukin diftitox (DB00004)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: GHRP-2 infusion
Trial: 10946861
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with E2 and GHRP-2
Trial: 7844011
Drug: Lead weights
RxNorm normalized name: lead
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lead weights (0.8 to 2.0 g) glued to the upper lid with adhesive (Combihesive* or Tesafix)
Trial: 3041973
Drug: Combination homeopathic
RxNorm normalized name: Urtica urens homeopathic preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination homeopathic preparation (Gripp-Heel)
Trial: 31493775
Drug: KC for
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: KC for 60 min daily
Trial: 31493775
Drug: KC for
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: KC for 120 min daily
Trial: 26196695
Drug: Linezolid (600-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid (600-mg twice daily)
Trial: 23630950
Drug: Aliskiren 300
RxNorm normalized name: aliskiren 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren 300 mg QD for 12 weeks
Trial: 23630950
Drug: Telmisartan 80
RxNorm normalized name: telmisartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 80 mg QD for 12 weeks
Trial: 20072091
Drug: Hextend (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hextend (15 mL/kg administered during surgery)
Trial: 20072091
Drug: Voluven (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voluven (15 mL/kg administered during surgery)
Trial: 16997114
Drug: Amlexanox oral
RxNorm normalized name: amlexanox Oral Paste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlexanox oral adhesive tablets applied 4 times a day for 5 days
Trial: 7790244
Drug: Conventional photon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional photon therapy (70 Gy/35 fractions/7 weeks)
Trial: 7790244
Drug: Conventional photon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional photon therapy
Trial: 2192184
Drug: Hythiol (L‐cysteine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hythiol (L‐cysteine)
Trial: 393182
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cimetidine (H2 antagonist) and chlorpheniramine (H1 antagonist)
Trial: 393182
Drug: Chlorpheniramine (H1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine (H1 antagonist)
Trial: 3259413
Drug: Cimetidine (H2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (H2 antagonist)
Trial: 6353233
Drug: other therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: other therapies
Trial: 30215466
Drug: Intravenous ondansetron
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ondansetron (4 mg, 5 min)
Trial: 30215466
Drug: Intramuscular ephedrine
RxNorm normalized name: Ephedrine
DrugBank: Ephedrine (DB01364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular ephedrine (25 mg, 25 min)
Trial: 30215466
Drug: Ringer (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer (500 ml, 20 min)
Trial: 24126180
Drug: Intracoronary injection
RxNorm normalized name: HELIUM 992 mL in 1 L INTRACORONARY GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary injection of autologous mononuclear stem cells
Trial: 22408779
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg weekly for 6 months
Trial: 22408779
Drug: Alendronate administered
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate administered after osseointegration for 6 months
Trial: 26439944
Drug: Levodopa infusion
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa infusion
Trial: 15845179
Drug: Continuous thoracic
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous thoracic radiation therapy (50 Gy delivered in 2.0-Gy fractions over 5 weeks)
Trial: 15845179
Drug: Interdigitating split-course
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interdigitating split-course thoracic radiation therapy (50 Gy delivered in 2.5-Gy fractions over 8 weeks)
Trial: 10630349
Drug: Herbal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal treatment prescribed by traditional healers
Trial: 10630349
Drug: Symptomatic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic treatment or acyclovir (Control)
Trial: 31050715
Drug: Acetaminophen (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (1,000 mg daily)
Trial: 31050715
Drug: Placebo (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (400 mg potassium daily)
Trial: 31050715
Drug: Empty control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empty control (no pill)
Trial: 26507858
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment with budesonide induction and azathioprine maintenance
Trial: 26507858
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment with open ileocaecal resection
Trial: 30901867
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg dexamethasone
Trial: 24299928
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg dexamethasone (Early)
Trial: 24299928
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg dexamethasone (Early)
Trial: 24299928
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg dexamethasone (Late)
Trial: 24299928
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg dexamethasone (Late)
Trial: 19021129
Drug: Pre-existing knowledge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-existing knowledge of chemotherapy-associated cognitive problems
Trial: 7852666
Drug: Theophylline (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (once daily slow-release, mean serum concentration 16 +/- 5 micrograms/ml)
Trial: 7852666
Drug: Cromolyn (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cromolyn (2 mg administered by MDI four times daily)
Trial: 7852666
Drug: Theophylline (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (once daily slow-release)
Trial: 498698
Drug: Alprenolol treatment
RxNorm normalized name: alprenolol
DrugBank: Alprenolol (DB00866)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprenolol treatment (200 to 400 mg twice daily)
Trial: 19527386
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg oral lycopene daily
Trial: 8882920
Drug: Cognitive-behavioural treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural treatment (CBT)
Trial: 17654408
Drug: Combined pharmacological
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined pharmacological and psychological treatment
Trial: 17654408
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (pharmacological and psychological)
Trial: 17654408
Drug: Generalized anxiety
RxNorm normalized name: celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Generalized anxiety disorder treatments
Trial: 29371105
Drug: Dolutegravir (DTG)
DrugBank: Dolutegravir (DB08930)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dolutegravir (DTG) in combination with one to two NRTIs
Trial: 29371105
Drug: Ritonavir-boosted protease
RxNorm normalized name: Ritonavir
DrugBank: Ritonavir (DB00503)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir-boosted protease inhibitors (PI/r) in combination with one to two NRTIs
Trial: 20975464
Drug: Heated lidocaine/tetracaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heated lidocaine/tetracaine patch (active patch)
Trial: 17942819
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (20 IU BID)
Trial: 16313838
Drug: Live attenuated
RxNorm normalized name: mumps, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live attenuated hepatitis A vaccine (H2 strain)
Trial: 16313838
Drug: Vaccine coverage
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine coverage
Trial: 12202710
Drug: Iopamidol with
RxNorm normalized name: Iopamidol
DrugBank: Iopamidol (DB08947)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iopamidol with iodine concentration of 370 mg/mL (Group B)
Trial: 12202710
Drug: Iopamidol with
RxNorm normalized name: Iopamidol
DrugBank: Iopamidol (DB08947)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iopamidol with iodine concentration of 300 mg/mL (Group A)
Trial: 8670596
Drug: Aminohexane bisphosphonate
RxNorm normalized name: methylene diphosphonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminohexane bisphosphonate 400 mg (AHBP)
Trial: 8670596
Drug: Oestradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oestradiol valerate 2 mg and dydrogesterone 5 mg (E/D)
Trial: 3533562
Drug: pindolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pindolol (10 mg)
Trial: 2872795
Drug: nadolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nadolol (80 mg)
Trial: 2872795
Drug: acebutolol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: acebutolol (400 mg)
Trial: 30176543
Drug: c.2990 G>T
FDA approved: no
EMA approved: no
PMDA approved: no
Description: c.2990 G>T variant in SAM
Trial: 27081036
Drug: CEpOP +/−
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEpOP +/− rituximab (R) with epirubicin (70 mg/m2/dose)
Trial: 27081036
Drug: CHOP +/−
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHOP +/− rituximab (R) with doxorubicin (50 mg/m2/dose)
Trial: 25352653
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine titrated to a fasting glucose level of ≤5.3 mmol/L (≤95 mg/dL)
Trial: 26082625
Drug: QVA149 110/50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QVA149 110/50 μg once daily
Trial: 24321804
Drug: Salmeterol-fluticasone (SFC)
RxNorm normalized name: FLUTICASONE/SALMETEROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol-fluticasone (SFC) 50/500 μg twice daily
Trial: 21402550
Drug: Antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral therapy (ART) concurrent with tuberculosis treatment for 6 months
Trial: 21402550
Drug: Tuberculosis treatment
RxNorm normalized name: Hydrazides for tuberculosis treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tuberculosis treatment alone
Trial: 2039205
Drug: Oral ofloxacin
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ofloxacin (400 mg twice a day)
Trial: 2039205
Drug: Parenteral antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral antibiotics (cefazolin, 1.0 g intravenously every 8 h, or ceftazidime, 2.0 g intravenously every 12 h)
Trial: 6753642
Drug: Thiopental, 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental, 15 mg/kg
Trial: 31257453
Drug: ETN 50
RxNorm normalized name: ETN
DrugBank: Erythrityl tetranitrate (DB01613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ETN 50 mg plus MTX
Trial: 27252426
Drug: ETN 25
RxNorm normalized name: ETN
DrugBank: Erythrityl tetranitrate (DB01613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ETN 25 mg plus MTX
Trial: 31257453
Drug: Full-/reduced-dose combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-/reduced-dose combination therapy (ETN 50 mg or 25 mg plus MTX)
Trial: 30996038
Drug: Generalizability (G)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generalizability (G) study
Trial: 9422404
Drug: Conventional CsA
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional CsA (Sandimmune formulation) and azathioprine (AZA)
Trial: 7795000
Drug: Multi-faceted treatment
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-faceted treatment program for violent spouses
Trial: 28389218
Drug: Walking training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Walking training (WT), n=22, 15 bouts of 2min of walking interpolated by 2min of upright rest, twice/week for 12 weeks
Trial: 28389218
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CG), n=20, 30min of stretching exercises, twice/week for 12 weeks
Trial: 25591836
Drug: Standard aromatase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard aromatase inhibitors (AI) alone
Trial: 18307371
Drug: Meropenem 500
RxNorm normalized name: meropenem 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 500 mg, 1000 mg, or 2000 mg every 6 or 8 hours by intravenous infusion
Trial: 16566555
Drug: Oxandrolone 10
RxNorm normalized name: oxandrolone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxandrolone 10 mg every 12 hours
Trial: 11051370
Drug: 5 mU
RxNorm normalized name: MULTISTIX 5 MULTIPLE TEST STRIP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mU interferon TIW for 6 months + ribavirin (1000‐1200 mg daily) if HCV‐RNA positive at month 3